Table 5 Summary of demographic and clinicopathologic data of 25 GISTs with primary KIT exon 17 mutations
Case | Age | Sex | Loc | Histology | Size (cm) | Mitosis/50 HPFs | Group (risk of MET in %) | Follw-up (months) |
|---|---|---|---|---|---|---|---|---|
1 | 62 | F | Stomach | Sp | 4.7 | 0 | 2 (1.9%) | UNK |
2 | 62 | M | Stomach | Sp | 4 | 1 | 2 (1.9%) | DUNC 199 |
3 | 64 | F | Stomach | Sp | 2.5 | 0 | 2 (1.9%) | ADSU 156 |
4 | 80 | F | Stomach | Sp | UNK | 1 | UNK | UNK |
5 | 49 | M | Small bowel | Sp | 18 | 3 | 3b (52%) | DOD 12 |
6 | 64 | F | Small bowel | Sp | 16 | 4 | 3b (52%) | DUNK 24 |
7 | 77 | M | Small bowel | UNK | 10 | UNK | UNK | IAB MET 56 |
8 | 46 | F | Small bowel | Sp | 8.3 | UNK | UNK | DUNK 36 |
9 | 64 | F | Small bowel | Sp+Ep | 8 | 0 | 3a (24%) | UNK |
10 | 50 | M | Small bowel | Sp | 6.2 | 4 | 3a (24%) | ANED 170 |
11 | 71 | F | Small bowel | Sp | 3 | 0 | 2 (4.3%) | ANED 67 |
12 | 61 | M | Small bowel/Mesenterium | Ep | 8 | 25 | 6a (85%) | IAB MET 46 |
13 | 44 | F | IAB | UNK | UNK | UNK | UNK | UNK |
14 | 65 | M | IAB | Sp | UNK | 8 | UNK | UNK |
